View Future GrowthLightAir 과거 순이익 실적과거 기준 점검 0/6LightAir은 연평균 2%의 비율로 수입이 증가해 온 반면, Consumer Durables 산업은 연평균 1.8%의 비율로 감소했습니다. 매출은 연평균 8.3%의 비율로 감소했습니다.핵심 정보1.96%순이익 성장률31.66%주당순이익(EPS) 성장률Consumer Durables 산업 성장률-0.085%매출 성장률-8.33%자기자본이익률-39.21%순이익률-51.22%최근 순이익 업데이트31 Dec 2025최근 과거 실적 업데이트Reported Earnings • Mar 03Full year 2023 earnings releasedFull year 2023 results: Revenue: kr16.3m (up 19% from FY 2022). Net loss: kr16.6m (loss narrowed 68% from FY 2022).Reported Earnings • Feb 28Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: kr17.4m (down 37% from FY 2020). Net loss: kr22.3m (loss widened 88% from FY 2020). Revenue was in line with analyst estimates.Reported Earnings • Jun 05Full year 2020 earnings released: kr0.36 loss per share (vs kr0.13 loss in FY 2019)The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: kr27.7m (up 129% from FY 2019). Net loss: kr11.9m (loss widened 315% from FY 2019). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.모든 업데이트 보기Recent updatesBoard Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Chairman Lars Andersson was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Mar 03Full year 2023 earnings releasedFull year 2023 results: Revenue: kr16.3m (up 19% from FY 2022). Net loss: kr16.6m (loss narrowed 68% from FY 2022).Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman of the Board Ulf Lindsten was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman of the Board Ulf Lindsten was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.Reported Earnings • Feb 28Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: kr17.4m (down 37% from FY 2020). Net loss: kr22.3m (loss widened 88% from FY 2020). Revenue was in line with analyst estimates.분석 기사 • Jun 06Companies Like LightAir (NGM:LAIR) Are In A Position To Invest In GrowthWe can readily understand why investors are attracted to unprofitable companies. For example, although...Reported Earnings • Jun 05Full year 2020 earnings released: kr0.36 loss per share (vs kr0.13 loss in FY 2019)The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: kr27.7m (up 129% from FY 2019). Net loss: kr11.9m (loss widened 315% from FY 2019). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.공고 • Mar 12Lightair AB (Publ) Receives an Order for Installation of LightAir Health+LightAir has received an order for a large installation of air purifiers and virus inhibitors within its Professional Solutions segment. The American International School of Bucharest has ordered an air purification capacity of approximately 100,000 m3/h, with complementary antiviral technology corresponding to more than 300 classrooms. The deal was secured by LightAir's Romanian partner Wellnessist and confirms the potential of the LightAir Health+ offer, targeting offices and schools. LightAir Health+ is an innovative solution for air purification that consists of two complementary technologies. First, highly efficient air purifiers that lower the concentration of air pollutants through filtration. As much as 99.99% of traffic pollutants, viruses and ultrafine particles are removed from the indoor air. The second component consists of patented virus inhibitors, which actively seek out and destroy residual airborne viruses in the air. The two technologies together thus provide double protection against airborne viruses.공고 • Mar 03Djurgården Hockey Installs Lightair Health+Djurgården Hockey has chosen the LightAir Health+ air purification system for its elite-level men's, women's and junior ice hockey teams. The advanced air purification solution is now being installed and will cover meeting rooms, changing rooms and gym. The solution being installed at Djurgården Hockey is offered in Sweden primarily on a subscription basis, where clean air is provided as a service - including installation and ongoing maintenance. The service doesn't tie up capital and comes with a lifetime warranty regarding hardware functionality.공고 • Dec 20LightAir AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 27.2 million.LightAir AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 27.2 million. Security Name: Shares Security Type: Common Stock Transaction Features: Rights Offering공고 • Dec 17LightAir Tests Air Purification Technology Against CoronavirusLightAir is initiating tests on coronavirus with a leading European virus research stitute. The tests will show h how well the Swedish company's IonFlow technology also prevents contact and airborne transmission of COVID19. A scientific study from Karolinska Institutet has previously shown that the technology inactivates influenza viruses immediately and continuously, and prevents airborne transmission. In the coming months, specific tests will be carried out to show how well IonFlow also neutralizes coronaviruses such as SARS-CoV-2, which causes the disease COVID19, and SARS-CoV-1, which causes the disease SARS. LightAirs patented IonFlow technology and its antiviral properties have previously been the subject of an extensive scientific research study, which was led by Professor Lennart Svensson, Linköping University Hospital, and Professor Hans Wigzell of Karolinska Institutet. The study, published in June 2015 in Nature Scientific Reports, concludes that IonFlow technology prevents contact-based and airborne transmission of the viruses examined, which included those causing influenza and winter vomiting disease.Is New 90 Day High Low • Dec 16New 90-day high: kr4.09The company is up 20% from its price of kr3.42 on 17 September 2020. The Swedish market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Durables industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 16New 90-day low: kr3.11The company is down 11% from its price of kr3.50 on 17 July 2020. The Swedish market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Durables industry, which is up 19% over the same period.매출 및 비용 세부 내역LightAir가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이NGM:LAIR 매출, 비용 및 순이익 (SEK Millions)날짜매출순이익일반관리비연구개발비31 Dec 2514-718030 Sep 2515-1520030 Jun 2516-2222031 Mar 2516-2424031 Dec 2417-2726030 Sep 2416-2326030 Jun 2416-1825031 Mar 2416-1824031 Dec 2316-1723030 Sep 2316-3223030 Jun 2316-4722031 Mar 2315-4922031 Dec 2214-5221030 Sep 2215-3921030 Jun 2216-2621031 Mar 2216-2420031 Dec 2117-2220030 Sep 2119-1918030 Jun 2120-1517031 Mar 2127-1317031 Dec 2028-1215030 Sep 2028-320030 Jun 2023-320031 Mar 2015-316031 Dec 1912-318030 Sep 198-1114030 Jun 198-1114031 Mar 198-1113031 Dec 1811-812030 Sep 1811-1415030 Jun 1815-1417031 Mar 1820-1418031 Dec 1722-1720030 Sep 1726-1519030 Jun 1725-1518031 Mar 1727-1519031 Dec 1629-15190양질의 수익: LAIR 은(는) 현재 수익성이 없습니다.이익 마진 증가: LAIR는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: LAIR는 수익성이 없지만 지난 5년 동안 연평균 2%의 속도로 손실을 줄였습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 LAIR의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: LAIR은 수익성이 없어 지난 해 수익 성장률을 Consumer Durables 업계(10%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: LAIR는 현재 수익성이 없으므로 자본 수익률이 음수(-39.21%)입니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YConsumer-durables 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/08/19 12:02종가2026/08/19 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스LightAir AB (publ)는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
Reported Earnings • Mar 03Full year 2023 earnings releasedFull year 2023 results: Revenue: kr16.3m (up 19% from FY 2022). Net loss: kr16.6m (loss narrowed 68% from FY 2022).
Reported Earnings • Feb 28Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: kr17.4m (down 37% from FY 2020). Net loss: kr22.3m (loss widened 88% from FY 2020). Revenue was in line with analyst estimates.
Reported Earnings • Jun 05Full year 2020 earnings released: kr0.36 loss per share (vs kr0.13 loss in FY 2019)The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: kr27.7m (up 129% from FY 2019). Net loss: kr11.9m (loss widened 315% from FY 2019). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
Board Change • May 20No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. Chairman Lars Andersson was the last director to join the board, commencing their role in 2024. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Mar 03Full year 2023 earnings releasedFull year 2023 results: Revenue: kr16.3m (up 19% from FY 2022). Net loss: kr16.6m (loss narrowed 68% from FY 2022).
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman of the Board Ulf Lindsten was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Chairman of the Board Ulf Lindsten was the last director to join the board, commencing their role in 2020. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
Reported Earnings • Feb 28Full year 2021 earnings: Revenues in line with analyst expectationsFull year 2021 results: Revenue: kr17.4m (down 37% from FY 2020). Net loss: kr22.3m (loss widened 88% from FY 2020). Revenue was in line with analyst estimates.
분석 기사 • Jun 06Companies Like LightAir (NGM:LAIR) Are In A Position To Invest In GrowthWe can readily understand why investors are attracted to unprofitable companies. For example, although...
Reported Earnings • Jun 05Full year 2020 earnings released: kr0.36 loss per share (vs kr0.13 loss in FY 2019)The company reported a decent full year result with improved revenues, although losses increased and control over costs was weaker. Full year 2020 results: Revenue: kr27.7m (up 129% from FY 2019). Net loss: kr11.9m (loss widened 315% from FY 2019). Over the last 3 years on average, earnings per share has increased by 68% per year but the company’s share price has only increased by 10% per year, which means it is significantly lagging earnings growth.
공고 • Mar 12Lightair AB (Publ) Receives an Order for Installation of LightAir Health+LightAir has received an order for a large installation of air purifiers and virus inhibitors within its Professional Solutions segment. The American International School of Bucharest has ordered an air purification capacity of approximately 100,000 m3/h, with complementary antiviral technology corresponding to more than 300 classrooms. The deal was secured by LightAir's Romanian partner Wellnessist and confirms the potential of the LightAir Health+ offer, targeting offices and schools. LightAir Health+ is an innovative solution for air purification that consists of two complementary technologies. First, highly efficient air purifiers that lower the concentration of air pollutants through filtration. As much as 99.99% of traffic pollutants, viruses and ultrafine particles are removed from the indoor air. The second component consists of patented virus inhibitors, which actively seek out and destroy residual airborne viruses in the air. The two technologies together thus provide double protection against airborne viruses.
공고 • Mar 03Djurgården Hockey Installs Lightair Health+Djurgården Hockey has chosen the LightAir Health+ air purification system for its elite-level men's, women's and junior ice hockey teams. The advanced air purification solution is now being installed and will cover meeting rooms, changing rooms and gym. The solution being installed at Djurgården Hockey is offered in Sweden primarily on a subscription basis, where clean air is provided as a service - including installation and ongoing maintenance. The service doesn't tie up capital and comes with a lifetime warranty regarding hardware functionality.
공고 • Dec 20LightAir AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 27.2 million.LightAir AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 27.2 million. Security Name: Shares Security Type: Common Stock Transaction Features: Rights Offering
공고 • Dec 17LightAir Tests Air Purification Technology Against CoronavirusLightAir is initiating tests on coronavirus with a leading European virus research stitute. The tests will show h how well the Swedish company's IonFlow technology also prevents contact and airborne transmission of COVID19. A scientific study from Karolinska Institutet has previously shown that the technology inactivates influenza viruses immediately and continuously, and prevents airborne transmission. In the coming months, specific tests will be carried out to show how well IonFlow also neutralizes coronaviruses such as SARS-CoV-2, which causes the disease COVID19, and SARS-CoV-1, which causes the disease SARS. LightAirs patented IonFlow technology and its antiviral properties have previously been the subject of an extensive scientific research study, which was led by Professor Lennart Svensson, Linköping University Hospital, and Professor Hans Wigzell of Karolinska Institutet. The study, published in June 2015 in Nature Scientific Reports, concludes that IonFlow technology prevents contact-based and airborne transmission of the viruses examined, which included those causing influenza and winter vomiting disease.
Is New 90 Day High Low • Dec 16New 90-day high: kr4.09The company is up 20% from its price of kr3.42 on 17 September 2020. The Swedish market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Consumer Durables industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 16New 90-day low: kr3.11The company is down 11% from its price of kr3.50 on 17 July 2020. The Swedish market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Durables industry, which is up 19% over the same period.